Mk. Oestreicher et al., GENETIC AND ENVIRONMENTAL-INFLUENCES ON N EUROMODULATION AND THE ANTINOCICEPTIVE EFFECT OF DEXTROMETHORPHAN, Schweizerische medizinische Wochenschrift, 128(6), 1998, pp. 212-215
Administration of NMDA antagonists leads to attenuation or disappearan
ce of some symptoms of central sensitization, such as secondary hypera
lgesia. However, the side effects of NMDA antagonists to a large exten
t counterbalance the expected benefits, thus preventing wide or prolon
ged use. Dextromethorphan and its metabolite dextrophan, on the other
hand, are established and safe drugs. Experimentally they both antagon
ize the NMDA receptor. This study evaluates the effects of dextrometho
rphan and its metabolite in pain models using electrical stimulation f
or testing the antinociceptive effect and capsaicin-induced hyperalges
ia. Dextromethorphan shows clear antinociceptive as well as neuromodul
ary effects, both depending heavily on the cytochrome P450 2D6 phenoty
pe (CYP2D6).